Cohen R J, Cuneo R A, Cruciger M P, Jackman A E
J Clin Oncol. 1983 Jun;1(6):392-3. doi: 10.1200/JCO.1983.1.6.392.
A 36-year-old man being treated with cisplatinum, vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a partial nondominant parietal lobe syndrome. He subsequently had a resolution of all signs and symptoms, suggesting that these alarming events were a toxic but reversible side effect of the chemotherapy.